The FDA studies on the pharmacokinetics of BPA have gone where no assessment of an environmental chemical has ever gone before in terms of scope and sophistication.

FORBES: Leading Environmental Group Scientist Praises FDA's Ground-Breaking Research On BPA: A Tipping Point In The Controversy?

Doerge has been leading a team investigating the pharmacokinetics (PK) of BPA, a term which refers to the way the chemical passes through and interacts with the body and its tissues.

FORBES: Leading Environmental Group Scientist Praises FDA's Ground-Breaking Research On BPA: A Tipping Point In The Controversy?